FLOT vs CROSS in Esophageal Adenocarcinoma

Дата публикации: 01-09-2026 00:00:00

This cohort study evaluates survival outcomes following FLOT chemotherapy vs CROSS chemoradiotherapy in patients with esophageal adenocarcinoma achieving pathological complete response.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FLOT-Induced vs CROSS-Induced Pathological Complete Response	0	8.96	01-09-2026
2	Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer	0	6.4	01-09-2026
3	MAIBE for Patients With Locally Advanced Pancreatic Cancer	0	5.92	01-09-2026
4	Lumpectomy Margins and Local Recurrence in DCIS	0	8.55	01-09-2026
5	Recalibrating “Unresectable” in Pancreatic Cancer	0	12.62	01-09-2026
6	Clinical trial to treat rectal cancer spares major surgery	0	8.49	24-08-2026
7	Tumor response to immunochemotherapy may spare some head and neck cancer patients radical surgery	0	7.22	10-09-2026
8	Robotic vs Laparoscopic Approach for Complex Elective Cholecystectomy	0	5.8	01-09-2026
9	Enucleation vs Pancreatoduodenectomy for Pancreatic Head Tumors	0	12.56	30-09-2026
10	Perioperative Toripalimab in Stage III Non–Small Cell Lung Cancer	0	14.35	01-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.05. Источник: archderm.jamanetwork.com.